161 related articles for article (PubMed ID: 38050610)
1. Gene mutation analysis of oral submucous fibrosis cancerization in Hainan Island.
Li B; Chen X; Xian H; Wen Q; Wang T
PeerJ; 2023; 11():e16392. PubMed ID: 38050610
[TBL] [Abstract][Full Text] [Related]
2. Study on the expression and function of smad family member 7 in oral submucous fibrosis and oral squamous cell carcinoma.
Hu X; Xiong H; Wang W; Huang L; Mao T; Yang L; Wang C; Huang D; Wu J; Xia K; Su T
Arch Oral Biol; 2020 Apr; 112():104687. PubMed ID: 32114253
[TBL] [Abstract][Full Text] [Related]
3. Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment.
Zhi Y; Wang Q; Zi M; Zhang S; Ge J; Liu K; Lu L; Fan C; Yan Q; Shi L; Chen P; Fan S; Liao Q; Guo C; Wang F; Gong Z; Xiong W; Zeng Z
Adv Sci (Weinh); 2024 Mar; 11(12):e2306515. PubMed ID: 38229179
[TBL] [Abstract][Full Text] [Related]
4. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.
Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S
BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276
[TBL] [Abstract][Full Text] [Related]
5. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
6. Change and pathological significance of glycogen content in oral squamous cell carcinoma and oral submucous fibrosis.
Nie H; Hu X; Xiong H; Zeng L; Chen W; Su T
Tissue Cell; 2024 Apr; 87():102337. PubMed ID: 38430849
[TBL] [Abstract][Full Text] [Related]
7. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
[TBL] [Abstract][Full Text] [Related]
8. IRF4 as a novel target involved in malignant transformation of oral submucous fibrosis into oral squamous cell carcinoma.
Meng L; Jiang Y; You J; Zhao P; Liu W; Zhao N; Yu Z; Ma J
Sci Rep; 2023 Feb; 13(1):2775. PubMed ID: 36797470
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of oral squamous cell carcinoma with oral submucous fibrosis.
Saalim M; Sansare K; Karjodkar FR; Johaley S; Ali IK; Sharma SR; Mehra A; Rahman B
J Cancer Res Ther; 2021; 17(6):1510-1514. PubMed ID: 34916386
[TBL] [Abstract][Full Text] [Related]
10. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
[TBL] [Abstract][Full Text] [Related]
11. p16 as an independent marker for detection of high-risk HPV in oral submucous fibrosis and oral squamous cell carcinoma.
Sudhakaran A; Hallikeri K; Babu B
Indian J Pathol Microbiol; 2019; 62(4):523-528. PubMed ID: 31611434
[TBL] [Abstract][Full Text] [Related]
12. Skewed Th17/Treg balance during progression and malignant transformation of oral submucous fibrosis.
Liu S; Liu Z; Shan Z; Liu Y; Chen T; Fang L; Quan H
Oral Dis; 2022 Nov; 28(8):2119-2130. PubMed ID: 33749974
[TBL] [Abstract][Full Text] [Related]
13. Relation of salivary MMP-8 with oral submucous fibrosis and oral squamous cell carcinoma: a cross sectional analytical study.
Kazmi A; Abbas Z; Saleem Z; Haider S; Farooqui WA; Ahmed S
BMJ Open; 2022 Dec; 12(12):e060738. PubMed ID: 36523229
[TBL] [Abstract][Full Text] [Related]
14. Correlation of epigenetic change and identification of risk factors for oral submucous fibrosis.
Xu C; Zhao J; Loo WT; Hao L; Wang M; Cheung MN; Dou Y; Yip AY; Ng EL; Chow LW; Liu Q
Int J Biol Markers; 2012 Dec; 27(4):e314-21. PubMed ID: 23250779
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
Choudhari S; Masne S; Bhandare P; Dhumal S
J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis.
Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L
Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151
[TBL] [Abstract][Full Text] [Related]
17. Carcinogenesis of Male Oral Submucous Fibrosis Alters Salivary Microbiomes.
Chen MY; Chen JW; Wu LW; Huang KC; Chen JY; Wu WS; Chiang WF; Shih CJ; Tsai KN; Hsieh WT; Ho YH; Wong TY; Wu JH; Chen YL
J Dent Res; 2021 Apr; 100(4):397-405. PubMed ID: 33089709
[TBL] [Abstract][Full Text] [Related]
18. [Expression of PTPRZ1 in oral squamous cell carcinoma originated from oral submucous fibrosis and its clinical significance].
Zhu R; Jian XC; Liu DY; Zhou C; Wang Y
Shanghai Kou Qiang Yi Xue; 2017 Apr; 26(2):198-203. PubMed ID: 28815252
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
[TBL] [Abstract][Full Text] [Related]
20. An Evaluation of Clinical and Histopathological Aspects of Patients with Oral Submucous Fibrosis in the Background of Oral Squamous Cell Carcinoma.
Siriwardena BSMS; Jayawardena KLTD; Senarath NH; Tilakaratne WM
Biomed Res Int; 2018; 2018():4154165. PubMed ID: 30402477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
